SIRT1 regulates lamellipodium extension and migration of melanoma cells

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Melanoma is a highly metastatic cancer.
• The precise mechanisms driving melanoma cell migration remain incompletely understood.
• Identifying key regulators of cell motility is crucial for developing anti-metastatic therapies.

Purpose of the Study:

• To investigate the role of nicotinamide adenine dinucleotide-dependent protein deacetylase (SIRT1) in melanoma cell migration and metastasis.
• To determine if SIRT1 inhibition can serve as a therapeutic strategy against melanoma metastasis.

Main Methods:

• Utilized SIRT1 inhibitors and small interfering RNAs (siRNAs) for SIRT1 knockdown in melanoma cells (B16F1).
• Assessed cell membrane extension, lamellipodium formation, and cellular motility.
• Investigated the involvement of signaling pathways including Rac1, Akt, and phosphatidylinositol-3,4,5-trisphosphate (PIP3) using techniques like fluorescence resonance energy transfer (FRET).
• Evaluated metastasis and survival in a mouse model (B16F1 cells in C57BL6/J mice).

Main Results:

• SIRT1 was localized in the cytoplasm and lamellipodium of migrating melanoma cells.
• SIRT1 inhibition or knockdown suppressed melanoma cell membrane extension, lamellipodium formation, and motility.
• SIRT1 activators enhanced melanoma cell protrusion and motility.
• SIRT1 inhibition blocked growth factor-induced lamellipodium extension and signaling pathway activation (Rac1, Akt phosphorylation, PIP3 levels).
• SIRT1 inhibition significantly reduced in vivo metastasis and improved survival in mice.
• SIRT1 knockdown also decreased melanoma metastasis in mice.

Conclusions:

• SIRT1 plays a critical role in regulating melanoma cell migration and metastasis.
• Inhibiting SIRT1 is a promising therapeutic strategy to suppress melanoma cell metastasis.
• Targeting SIRT1 may offer a novel approach to improve outcomes for melanoma patients.